FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats

FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats

© 2016 Elsevier Inc. Fibroblast growth factor 21 (FGF21) is an endocrine hormone which exerts beneficial effects on metabolic regulation in obese and diabetic models. However, the effect of FGF21 on cognition in obese-insulin resistant rats has not been investigated. We hypothesized that FGF21 preve...

Saved in:

書目詳細資料
Main Authors:	Piangkwan Sa-nguanmoo, Pongpan Tanajak, Sasiwan Kerdphoo, Pattarapong Satjaritanun, Xiaojie Wang, Guang Liang, Xiaokun Li, Chao Jiang, Wasana Pratchayasakul, Nipon Chattipakorn, Siriporn C. Chattipakorn
格式:	雜誌
出版:	2018
主題:	Biochemistry, Genetics and Molecular Biology Neuroscience
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84983605315&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/55151
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats
由: Sa-nguanmoo P., et al.
出版: (2017)

FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats
由: Piangkwan Sa-nguanmoo, et al.
出版: (2018)

FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats
由: Piangkwan Sa-nguanmoo, et al.
出版: (2018)

SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
由: Piangkwan Sa-nguanmoo, et al.
出版: (2018)

SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
由: Piangkwan Sa-nguanmoo, et al.
出版: (2018)

Energy restriction combined with dipeptidyl peptidase-4 inhibitor exerts neuroprotection in obese male rats
由: Hiranya Pintana, et al.
出版: (2018)

Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance
由: Jitjiroj Ittichaicharoen, et al.
出版: (2018)

Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance
由: Jitjiroj Ittichaicharoen, et al.
出版: (2018)

DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats
由: Sripetchwandee,J., et al.
出版: (2015)

DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats
由: Sripetchwandee,J., et al.
出版: (2015)

DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats
由: Sripetchwandee,J., et al.
出版: (2015)

Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats
由: Narattaphol Charoenphandhu, et al.
出版: (2018)

Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats
由: Narattaphol Charoenphandhu, et al.
出版: (2018)

Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats
由: Narattaphol Charoenphandhu, et al.
出版: (2018)

Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats
由: Pongpan Tanajak, et al.
出版: (2018)

Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats
由: Pongpan Tanajak, et al.
出版: (2018)

Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats
由: Pongpan Tanajak, et al.
出版: (2018)

Synaptic regulation of microtubule dynamics in dendritic spines by calcium, F-actin, and Drebrin
由: Elliott B. Merriam, et al.
出版: (2018)

Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats
由: Wasana Pratchayasakul, et al.
出版: (2018)

Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats
由: Wasana Pratchayasakul, et al.
出版: (2018)

Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats
由: Hiranya Pintana, et al.
出版: (2018)

Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats
由: Hiranya Pintana, et al.
出版: (2018)

Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions
由: Wasana Pratchayasakul, et al.
出版: (2018)

Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions
由: Wasana Pratchayasakul, et al.
出版: (2018)

Reversible acetylcholinesterase inhibitory effect of Tabernaemontana divaricata extract on synaptic transmission in rat CA1 hippocampus
由: Wasana Pratchayasakul, et al.
出版: (2018)

Chronic high-fat diet consumption induces an alteration in plasma/brain neurotensin signaling, metabolic disturbance, systemic inflammation/oxidative stress, brain apoptosis, and dendritic spine loss
由: Napatsorn Saiyasit, et al.
出版: (2020)

Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: The different roles of FGF21
由: Arintaya Phrommintikul, et al.
出版: (2018)

Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: The different roles of FGF21
由: Arintaya Phrommintikul, et al.
出版: (2018)

Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: The different roles of FGF21
由: Arintaya Phrommintikul, et al.
出版: (2019)

Estrogen restores brain insulin sensitivity in ovariectomized non-obese rats, but not in ovariectomized obese rats
由: Wasana Pratchayasakul, et al.
出版: (2018)

Estrogen restores brain insulin sensitivity in ovariectomized non-obese rats, but not in ovariectomized obese rats
由: Wasana Pratchayasakul, et al.
出版: (2018)

Activating transcription factor 4 (ATF4) modulates post-synaptic development and dendritic spine morphology
由: Liu, J, et al.
出版: (2020)

Letter to the editor: Parameters, characteristics, and criteria for defining the term "fGF21 resistance"
由: Pongpan Tanajak
出版: (2018)

Letter to the editor: Parameters, characteristics, and criteria for defining the term "fGF21 resistance"
由: Pongpan Tanajak
出版: (2018)

Impaired mitochondria and intracellular calcium transients in the salivary glands of obese rats
由: Jitjiroj Ittichaicharoen, et al.
出版: (2018)

Impaired mitochondria and intracellular calcium transients in the salivary glands of obese rats
由: Jitjiroj Ittichaicharoen, et al.
出版: (2018)

Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats
由: Tanajak P., et al.
出版: (2017)

Atorvastatin and insulin equally mitigate brain pathology in diabetic rats
由: Wasana Pratchayasakul, et al.
出版: (2018)

Atorvastatin and insulin equally mitigate brain pathology in diabetic rats
由: Wasana Pratchayasakul, et al.
出版: (2018)

Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats
由: P. Tanajak, et al.
出版: (2018)